NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00409-1144-05 — verapamil 2.5 mg/mL intravenous solutionAI (580 hospitals, 61,237–62,740 samples)
• NDC 00781-3152-95 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (264 hospitals, 61,417–62,722 samples)
• NDC 63323-0201-10 — Lidocaine 1% injection solutionAI (921 hospitals, 53,864–62,675 samples)
• NDC 63323-0462-17 — Sensorcaine with epinephrine local anesthetic injectionAI (597 hospitals, 61,193–62,498 samples)
• NDC 00409-7295-11 — Potassium phosphate injectionAI (505 hospitals, 59,472–62,334 samples)
• NDC 00409-7517-16 — Dextrose 50% injectionAI (710 hospitals, 60,503–62,240 samples)
• NDC 70069-0021-25 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (726 hospitals, 53,589–62,220 samples)
• NDC 00487-9501-01 — Albuterol sulfate 2.5 mg nebulizer solutionAI (830 hospitals, 58,669–62,206 samples)
• NDC 00409-4755-18 — Ondansetron injection, 4 mg per 2 mLAI (411 hospitals, 54,541–62,128 samples)
• NDC 00409-4279-16 — Lidocaine 1% numbing injection, preservative-freeAI (433 hospitals, 56,171–62,120 samples)
• NDC 63323-0781-10 — Vecuronium IV muscle relaxant, 10 mgAI (351 hospitals, 59,895–62,100 samples)
• NDC 00338-0043-04 — Half-strength saline IV solutionAI (762 hospitals, 59,194–62,056 samples)
• NDC 51754-0108-01 — Tranexamic acid in saline IV bagAI (591 hospitals, 59,514–61,989 samples)
• NDC 00409-1632-01 — Vecuronium bromide 10 mg injectionAI (285 hospitals, 60,738–61,890 samples)
• NDC 50419-0325-02 — Gadobutrol contrast injection for imagingAI (278 hospitals, 58,173–61,791 samples)
• NDC 00409-7248-03 — Hetastarch 6% in sodium chloride IV solutionAI (385 hospitals, 60,433–61,783 samples)
• NDC 00409-3375-04 — Norepinephrine intravenous solutionAI (577 hospitals, 60,534–61,740 samples)
• NDC 00409-7391-72 — Sodium phosphate injection, multiple strengthsAI (740 hospitals, 59,862–61,716 samples)
• NDC 00019-1323-21 — Ioversol contrast dye for imaging, IV solutionAI (68 hospitals, 60,952–61,681 samples)
• NDC 00641-6078-25 — Ondansetron 4 mg/2 mL injectionAI (664 hospitals, 56,957–61,673 samples)
• NDC 00143-9318-10 — Norepinephrine 1 mg/mL IV solutionAI (304 hospitals, 60,582–61,671 samples)
• NDC 00143-9509-01 — Ketamine hydrochloride injection, 100 mg/mLAI (399 hospitals, 60,001–61,630 samples)
• NDC 76204-0200-01 — Albuterol sulfate 2.5 mg nebulizer solutionAI (730 hospitals, 58,005–61,596 samples)
• NDC 76204-0600-01 — Ipratropium-albuterol nebulizer solutionAI (707 hospitals, 58,930–61,585 samples)
• NDC 63323-0162-03 — Ketorolac injection 60 mg/2 mLAI (344 hospitals, 55,560–61,563 samples)
• NDC 00409-9094-18 — Fentanyl citrate injection, preservative-free, 250 mcg per 5 mLAI (427 hospitals, 40,354–61,531 samples)
• NDC 67457-0438-00 — Vecuronium bromide injection 10 mgAI (361 hospitals, 59,694–61,494 samples)
• NDC 17478-0711-10 — Lidocaine 2% numbing jelly, 5 mL tubeAI (410 hospitals, 60,415–61,441 samples)
• NDC 14789-0250-10 — EPHEDRINE SULFATE 5 MG/ML INTRAVENOUS SOLUTIONAI (294 hospitals, 60,003–61,380 samples)
• NDC 66794-0230-42 — Dexmedetomidine IV solution 200 mcg/2 mLAI (432 hospitals, 59,881–61,375 samples)
• NDC 00487-0201-01 — Ipratropium-albuterol nebulizer solutionAI (830 hospitals, 58,759–61,369 samples)
• NDC 68462-0755-01 — Ketorolac 15 mg/mL injectionAI (174 hospitals, 59,748–61,359 samples)
• NDC 00409-4888-02 — Sodium chloride 0.9% preservative-free injectionAI (414 hospitals, 51,677–61,343 samples)
• NDC 00264-5535-32 — Metronidazole 500 mg intravenous infusionAI (490 hospitals, 60,681–61,320 samples)
• NDC 76329-3015-05 — Lidocaine 2% jelly syringe, 20 mLAI (496 hospitals, 59,613–61,269 samples)
• NDC 00409-9042-01 — Bupivacaine with epinephrine (preservative-free) 0.25% injectionAI (432 hospitals, 59,750–61,262 samples)
• NDC 00641-6145-25 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (458 hospitals, 48,907–61,237 samples)
• NDC 80830-2329-02 — Tranexamic acid intravenous infusion, 1,000 mg in 100 mLAI (322 hospitals, 59,429–61,211 samples)
• NDC 00641-6145-01 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (414 hospitals, 55,367–61,199 samples)
• NDC 00407-2223-01 — Iodixanol 320 mg/mL contrast solutionAI (96 hospitals, 58,935–61,095 samples)
• NDC 00143-9784-01 — Flumazenil injection (IV reversal medication)AI (471 hospitals, 59,952–61,086 samples)
• NDC 00409-3299-05 — Sodium acetate intravenous solutionAI (350 hospitals, 60,055–61,054 samples)
• NDC 69374-0957-10 — Phenylephrine 100 mcg/mL IV syringeAI (413 hospitals, 57,276–61,038 samples)
• NDC 23155-0550-31 — Ondansetron 2 mg/mL IV solutionAI (147 hospitals, 56,899–61,012 samples)
• NDC 47335-0703-52 — Albuterol nebulizer solutionAI (236 hospitals, 59,730–60,909 samples)
• NDC 63323-0461-01 — Bupivacaine with epinephrine 0.25% injectionAI (281 hospitals, 59,748–60,819 samples)
• NDC 00517-2502-10 — Caffeine and sodium benzoate injectionAI (687 hospitals, 59,264–60,812 samples)
• NDC 00338-9543-06 — Normal saline IV infusion, 1000 mLAI (163 hospitals, 59,720–60,665 samples)
• NDC 00338-1130-03 — Amino acid 10% intravenous solutionAI (284 hospitals, 58,935–60,663 samples)
• NDC 63323-0117-61 — Fluorouracil 5 g/100 mL IV solutionAI (719 hospitals, 60,143–60,620 samples)